资讯

Moderna gets full FDA approval for kids COVID-19 vaccine
The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.
Medical Dialogues21 小时
Moderna Spikevax gets full USFDA nod for kids 6 months through 11 years at increased COVID risk
Cambridge: Moderna has received approval from the U.S. Food and Drug Administration (FDA) for the supplemental Biologics ...